We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
85 hedge funds and large institutions have $127M invested in CASI Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
260% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 5
100% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 16
16% more funds holding
Funds holding: 73 → 85 (+12)
4% more capital invested
Capital invested by funds: $122M → $127M (+$5.21M)
0.45% more ownership
Funds ownership: 3.34% → 3.8% (+0.45%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
85
Holders Change
+12
Holders Change %
+16.44%
% of All Funds
1.49%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
18
Increased
32
Reduced
16
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.85M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$8.32M |
| 3 |
TLP
Tri Locum Partners
New York
|
+$4.21M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.55M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$1.83M |
Top Sellers
| 1 |
Northern Trust
Chicago,
Illinois
|
-$336K |
| 2 |
Morgan Stanley
New York
|
-$144K |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$133K |
| 4 |
Millennium Management
New York
|
-$124K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$100K |
